River Plate/Alcon's dry eye treatment needs more study, US panel says
This article was originally published in Scrip
Executive Summary
The efficacy of River Plate Biotechnology/Alcon's dry eye treatment Rejena (sodium hyaluronate ophthalmic solution, 0.18%) requires further study before approval, the US FDA's dermatologic and ophthalmic drugs advisory panel has recommended.